Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 6,026–6,050 of 7,816 matching trials · page 242 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Inhaled Loxapine vs Intramuscular (IM) Haloperidol + Lorazepam for Agitation NCT03110900 Haloperidol + lorazepam; Loxapine Runs in: United States · 1 site |
PHASE4 other |
TERMINATED | 2 | University of Arkansas OTHER |
2018-06-11 |
|
Memory and Attention Disorders and Malnutrition in Hospital Setting NCT03252054 Screening for memory disorders, attention disorders, and malnutrition |
NA other |
COMPLETED | 151 | Tampere University Hospital OTHER |
2018-06-08 |
|
Reducing Care-Resistant Behaviors During Oral Hygiene in Persons With Dementia NCT01363258 Care-resistant mouth care (MOUTh); Evidence-based mouth care Runs in: United States · 4 sites |
NA other |
COMPLETED | 100 | University of Alabama at Birmingham OTHER |
2018-06-07 |
|
Efficacy and Safety Study of ABT-288 in Subjects With Mild-to-Moderate Alzheimer's Disease NCT01018875 ABT-288; donepezil; placebo Runs in: Russia; Ukraine · 21 sites |
PHASE2 symptomatic-cholinergic |
COMPLETED | 242 | AbbVie (prior sponsor, Abbott) INDUSTRY |
2018-06-06 |
|
Efficacy of Circadin® 2 mg in Patients With Mild to Moderate Alzheimer Disease Treated With AChE Inhibitor NCT00940589 Circadin; Placebo Runs in: Israel; United Kingdom; United States · 6 sites |
PHASE2 other |
COMPLETED | 73 | Neurim Pharmaceuticals Ltd. INDUSTRY |
2018-06-01 |
|
Ferumoxytol-enhanced Brain MRI in HIV-associated Neurocognitive Disorders NCT01665846 Ferumoxytol Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 4 | University of Hawaii OTHER |
2018-06-01 |
|
An Intervention to Reduce Inappropriate Medications in Long-term Care Residents With Severe Dementia NCT03539276 Knowledge exchange Runs in: Canada · 1 site |
NA other |
COMPLETED | 44 | CHU de Quebec-Universite Laval OTHER |
2018-06-01 |
|
Divalproex Sodium ER in Adult Autism NCT00211796 Divalproex Sodium ER Runs in: United States · 1 site |
PHASE4 other |
COMPLETED | 10 | Montefiore Medical Center OTHER |
2018-05-31 |
|
Normative Values for the German Version of the Montreal Cognitive Assessment (MoCA) NCT03246269 MoCA |
NA other |
COMPLETED | 334 | Andreas Monsch OTHER |
2018-05-31 |
|
Alzheimer's Disease and Physiological, Cognitive Function and BDNF Levels of Plasma Adaptation After Exercise Training NCT02968875 Endurance Training; therapeutic education meetings Runs in: Martinique · 1 site |
NA other |
COMPLETED | 54 | University Hospital Center of Martinique OTHER |
2018-05-29 |
|
Appropriate Compatibility of Propofol and Sevoflurane for Orthopaedic Surgery of Patients With MCI NCT03165396 Propofol; Sevoflurane Runs in: China · 1 site |
NA other |
UNKNOWN | 100 | The Third Central Clinical College of Tianjin Medical University OTHER |
2018-05-25 |
|
Validating Studies to Assess the Diagnostic Accuracy of a Software Application for Detection and Monitoring of Attentional Deficits in Delirium NCT02590796 No intervention given to participants Runs in: United Kingdom · 2 sites |
NA other |
COMPLETED | 907 | University of Edinburgh OTHER |
2018-05-24 |
|
Validation of the Sleep Assessment Algorithm in the Medical Application Nightly NCT03532269 Nightly App Runs in: Poland · 1 site |
NA other |
COMPLETED | 30 | DreamJay Sp. z o. o. INDUSTRY |
2018-05-22 |
|
Beam Walking Across the Lifespan for Falls Prediction NCT03532984 Beam test to predict falls Runs in: Brazil; Germany; Hungary; Japan; Netherlands · 5 sites |
NA other |
UNKNOWN | 432 | University Medical Center Groningen OTHER |
2018-05-22 |
|
Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease NCT01561430 LY2886721; Placebo Runs in: Italy; Japan; Netherlands; Spain; United States · 34 sites |
PHASE1|PHASE2 other |
TERMINATED | 70 | Eli Lilly and Company INDUSTRY |
2018-05-18 |
|
Neurofeedback Training for Older Adults With Mild Cognitive Impairment: a Protocol Study NCT03526692 Neurofeedback |
NA other |
UNKNOWN | 60 | Fabienne Marlats OTHER |
2018-05-18 |
|
Tau Imaging of Chronic Traumatic Encephalopathy NCT02191267 [F18]-T807; [F18]-Florbetapir; MRI/MRS; Genetic Analysis for Geneti... Runs in: United States · 2 sites |
PHASE2 other |
COMPLETED | 30 | Brigham and Women's Hospital OTHER |
2018-05-17 |
|
NRC:Improving Healthcare for Cognitively Impaired Elders and Their Caregivers NCT03289377 RDAD Training Runs in: United States · 1 site |
NA other |
UNKNOWN | 50 | University of Washington OTHER |
2018-05-15 |
|
Modified Environment for Agitation in Patients With TBI NCT02524067 Multifactorial circadian concept Runs in: Denmark · 1 site |
NA other |
COMPLETED | 20 | University of Aarhus OTHER |
2018-05-11 |
|
Group Reminiscence Therapy for Elderly People With Cognitive Decline in Institutional Context NCT03370796 Reminiscence Therapy Program Runs in: Portugal · 1 site |
NA other |
UNKNOWN | 50 | Escola Superior de Enfermagem de Coimbra OTHER |
2018-05-11 |
|
Therapy Light Rooms for Improved Sleep in Dementia Patients NCT03357328 Therapy light room; Standard light Runs in: Norway · 1 site |
NA other |
COMPLETED | 70 | University of Bergen OTHER |
2018-05-07 |
|
Cognitive Stimulation in the Elderly: Individual Intervention on Cognitive Frailty NCT03514095 Individual Cognitive Stimulation Therapy Program Runs in: Portugal · 1 site |
NA other |
UNKNOWN | 80 | Escola Superior de Enfermagem de Coimbra OTHER |
2018-05-07 |
|
A Psychosocial Intervention for Bereaved Spousal Caregivers of Persons With Dementia NCT02672800 the Reclaiming Yourself tool Runs in: Canada · 1 site |
NA other |
COMPLETED | 16 | University of Saskatchewan OTHER |
2018-05-04 |
|
The Aerobic & Cognitive Exercise Study NCT02237560 Cybercycle-Game; Cybercyle-Tour; Game Only Runs in: United States · 12 sites |
NA other |
COMPLETED | 111 | Union College, New York OTHER |
2018-05-03 |
|
UCLA Fitness and Memory Study of Activity In Mild Cognitive Impairment (AIM) NCT02001441 Runs in: United States · 1 site |
NA other |
COMPLETED | 35 | University of California, Los Angeles OTHER |
2018-05-02 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial